ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

MRNA-1365

A development code. Also written as “mRNA-1365 (Profile 2)” and “mRNA-1365”.

Its studies are led by Moderna.

Furthest: phase 1, since Feb 15, 20232 company-led studies, 2 open or runningNext primary completion: Jul 20, 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Moderna22 open or runningphase 1since Feb 15, 2023Feb 15, 2023Jul 20, 2027phase 1 · NCT07764237

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 15, 2023First study: phase 1 study in Respiratory Syncytial VirusFirst studyNCT05743881 · 186 enrolled · United States, Panama, United Kingdom
  2. Aug 10, 2026Phase 1 study in Respiratory Syncytial Virus (RSV)NCT07764237 · 375 planned · Canada, United Kingdom

Ahead

  1. Jul 20, 2027Primary completion: phase 1 study in Respiratory Syncytial Virus (RSV)NCT07764237
  2. Aug 31, 2029Primary completion: phase 1 study in Respiratory Syncytial VirusNCT05743881

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07764237Respiratory Syncytial Virus (RSV) · Canada, United Kingdom1RecruitingJul 20, 2027375
NCT05743881Respiratory Syncytial Virus · United States, Panama, United Kingdom1Active, not recruitingAug 31, 2029186

How it is read

Names in the registry

  • “mRNA-1365 (Profile 2)”, 1 entry
  • “mRNA-1365”, 1 entry

Codes read as this program: MRNA1365.

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.